Skin Cancer/Melanoma

May is National Melanoma and Skin Cancer Awareness Month, so we took a look at some of the top stories about the disease from 2023.

The addition of a personalized cancer vaccine to Keytruda led to a 44% reduction in the risk of death or recurrence in certain patients with melanoma.

I recently experienced scanxiety after a skin check-up showed something suspicious.

I felt a kinship with the main character in the book, “A Man Called Ove,” though luckily, I had a purpose after my wife died of melanoma, and that helped to keep me going.

Two clinical trials investigating Keytruda plus Lenvima will be discontinued after the drug duo was not superior to other regimens for melanoma and colorectal cancer subsets.

From the reveal of Christine McVie’s cause of death to cancer news from Hugh Jackman and a U.S. congressman, here’s what’s happening in the oncology space this week.

From the San Diego Padres’ coach missing Opening Day for colon cancer surgery to WWE star Alexa Bliss sharing her skin cancer experience and warning people against tanning beds, here’s what’s happening in the oncology space this week.

A marathon runner who was diagnosed with metastatic melanoma learned that what she enjoyed doing before cancer could help her regain her energy and identity during and after treatment.

Patients with advanced melanoma who followed the Mediterranean diet tended to have improved responses to immunotherapy treatment, recent research showed.

When all is said and done what is important to me was that we did all we could to save her. And when that failed, we did all we could to make her passing as peaceful as possible.

This FDA approval of Zynyz was based on findings from a study which demonstrated that the therapy improves responses in patients with locally advanced Merkel cell carcinoma.

The Food and Drug Administration accepted a supplemental Biologics License Application for Opdivo to treat stage 2B or C, fully resected melanoma.

The designation is based on study findings demonstrating that the cancer vaccine-Keytruda combination reduces the risk of recurrence or death by 44% in the adjuvant setting for patients with melanoma.

Many men — my former self included — can be stubborn when it comes to cancer screenings or visiting the doctor. Thankfully I’ve changed my ways, which saved my life.

From Michael Bublé opening up about his son’s cancer diagnosis to the death of “Enkyboys” social media star, here’s what’s happening in the oncology space this week.

Skin cancer can also occur in the nail area and may be associated with HPV, it may not be as common for it to result from a cut experienced during a manicure, one expert explained.

From the cancer diagnoses of an MLB pitcher and star of Riverdance to First Lady Jill Biden’s recent carcinoma removal, here’s what’s happening in the cancer space this week.

From tennis star Martina Navratilova’s two cancer diagnoses to First Lady Jill Biden undergoing Mohs surgery to have a suspicious lesion removed and musician deaths, here’s what’s happening in the cancer space this week.

A phase 2 trial evaluating EVX-01 plus Keytruda (pembrolizumab) in patients with metastatic melanoma may continue, the FDA said.

Although triplet therapy may be effective and tolerable for patients with BRAF-mutant melanoma, each patient’s case should be considered before deciding if it is the right course of treatment, according to an expert.

Men often decide to tough out their cancer alone, but tough guy Terry Bradshaw is starting to open up about his sometimes-rocky journey with the disease.

Patient-reported quality of life was better for patients with resected melanoma who received Keytruda compared to interferon or Yervoy, study results showed.

From a childhood cancer survivor throwing out the first pitch at Game 4 of the World Series to former WWE champion and actor Dwayne “The Rock” Johnson recording a message for a child with brain cancer, here’s what’s happening in the cancer space this week.

Talking about the end of life can be difficult, but these conversations are crucial for patients with incurable cancer to have with their clinicians, experts say.

When given after surgery, Opdivo improved relapse-free survival compared to placebo in patients with stage 2B or 2C skin cancer, according to recent results from the CheckMate-76K clinical trial.